Revvity (RVTY) EBT Margin Growth (1y) (2010 - 2026)
Powered by 
Analysis
Revvity (RVTY) EBT Margin Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 30.00 |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | 617.00 |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 258.00 |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | -646.00 |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | -82.00 |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 2,922.00 |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | 1,974.00 |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | -305.00 |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | -3,374.00 |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | -683.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 5, 2026 | -82.00 |
| Apr 5, 2026 | -85.00 |
| Dec 28, 2025 | -111.00 |
| Sep 28, 2025 | -670.00 |
| Jun 29, 2025 | -300.00 |
| Mar 30, 2025 | 256.00 |
| Sep 29, 2024 | 713.00 |
| Jun 30, 2024 | 244.00 |
| Mar 31, 2024 | 95.00 |
| Oct 1, 2023 | -400.00 |
| Jul 2, 2023 | -1,295.00 |
| Apr 2, 2023 | -1,899.00 |
| Jan 1, 2023 | -1,048.00 |
| Oct 2, 2022 | -414.00 |
| Jul 3, 2022 | -1,005.00 |
| Apr 3, 2022 | -2,214.00 |
| Jan 2, 2022 | -577.00 |
| Oct 3, 2021 | -857.00 |
| Jul 4, 2021 | 1,278.00 |
| Apr 4, 2021 | 4,017.00 |